US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Genfit

9.25

0.0000

Volume:- -

Turnover:- -

Market Cap:460.27M

PE:-14.39

High:9.25

Open:9.25

Low:9.25

Close:9.25

52wk High:9.25

52wk Low:3.28

Shares:49.76M

Float Shares:41.85M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6426

EPS(LYR):-0.6426

ROE:-51.74%

ROA:-8.54%

PB:7.43

PE(LYR):-14.39

Loading ...

Overview Company News Filings

Analysts’ Top Healthcare Picks: Genfit (GNFTF), Nyxoah (NYXH)

Genfit Advances Liver Pipeline With Completed Phase 1 G1090N Study

Kepler Capital Remains a Buy on Genfit (GNFTF)

GENFIT 9-Months 2025 Revenue €39.2 Million; Says As of September 30, 2025, The Company's Cash And Cash Equivalents Amounted To €119.0 Million Compared With €107.5 Million As Of June 30, 2025, And €81.8 Million As Of December 31, 2024

GENFIT Unveils Promising Preclinical Data for ACLF Treatment

GENFIT Collaborates with EVerZom to Advance Exosome-Based Therapy for ACLF

Genfit announces intention to voluntarily delist ADSs from Nasdaq

GENFIT Showcases ACLF Pipeline Advances at AASLD Liver Meeting 2025

Genfit Is Maintained at Buy by HC Wainwright & Co.

Genfit price target lowered to $7 from $9 at H.C. Wainwright

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Genfit (OtherGNFTF), Sanofi (OtherSNYNF) and Roche Holding AG (OtherRHHVF)

Genfit’s 2025 Mid-Year Financial and Strategic Update

Genfit SA Reports Revenue Decline and Net Loss

Genfit H1 EPS $(0.23) Down From $0.57 YoY, Sales $40.443M Down From $65.887M YoY

Genfit Discontinues VS-01 in ACLF After Safety Signal

MT Newswires Live

GENFIT Discontinues VS-01 Program in ACLF to Focus on UCD

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GNFTF/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNFTF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNFTF\",,,,,undefined,":{"symbol":"GNFTF","market":"US","secType":"STK","nameCN":"Genfit","latestPrice":9.25,"timestamp":1771863960000,"preClose":9.25,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":41846888,"shares":49758671,"eps":-0.642605,"marketStatus":"Trading","change":0,"latestTime":"02-23 11:26:00 EST Delay","open":9.25,"high":9.25,"low":9.25,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.642605,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771880400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":9.25,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNFTF\",,,,,undefined,":{"symbol":"GNFTF","floatShares":41846888,"roa":"-8.54%","roe":"-51.74%","lyrEps":-0.642605,"shares":49758671,"dividePrice":0,"high":9.25,"amplitude":0,"preClose":9.25,"low":9.25,"week52Low":3.2801,"pbRate":"7.43","psRate":"8.64","week52High":9.25,"institutionHeld":0,"latestPrice":9.25,"eps":-0.642605,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.642605,"open":9.25,"prevYearClose":6,"prevWeekClose":9.25,"prevMonthClose":6,"prevQuarterClose":6,"fiveDayClose":8.03,"twentyDayClose":6,"sixtyDayClose":4.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNFTF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-11-10","symbol":"GNFTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1668056400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-09-28","symbol":"GNFTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1664337600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-04-07","symbol":"GNFTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1649304000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNFTF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNFTF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1758344400000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNFTF\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611821147","title":"Analysts’ Top Healthcare Picks: Genfit (GNFTF), Nyxoah (NYXH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2611821147","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611821147?lang=en_us&edition=fundamental","pubTime":"2026-02-15 09:40","pubTimestamp":1771119627,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Genfit (GNFTF – Research Report) and Nyxoah (NYXH – ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-genfit-gnftf-nyxoah-nyxh-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-genfit-gnftf-nyxoah-nyxh-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","LU0029874061.USD","BK4588","BK4137","GNFTF","BK4581","LABU","NYXH","HCSG","LU0128526141.USD","BK4585","BK4139","XBI","BK4082"],"gpt_icon":0},{"id":"2604904139","title":"Genfit Advances Liver Pipeline With Completed Phase 1 G1090N Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2604904139","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604904139?lang=en_us&edition=fundamental","pubTime":"2026-01-17 00:30","pubTimestamp":1768581052,"startTime":"0","endTime":"0","summary":"Genfit ($GNFTY) announced an update on their ongoing clinical study. Study Overview Genfit is running a Phase 1 clinical study to test a new capsul...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfit-advances-liver-pipeline-with-completed-phase-1-g1090n-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfit-advances-liver-pipeline-with-completed-phase-1-g1090n-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GNFTF"],"gpt_icon":0},{"id":"2602294317","title":"Kepler Capital  Remains a Buy on Genfit (GNFTF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602294317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602294317?lang=en_us&edition=fundamental","pubTime":"2026-01-09 09:37","pubTimestamp":1767922659,"startTime":"0","endTime":"0","summary":"Kepler Capital analyst Justine Telliez maintained a Buy rating on Genfit on January 7 and set a price target of €8.40. The company’s shares closed ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-remains-a-buy-on-genfit-gnftf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-remains-a-buy-on-genfit-gnftf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF","BK4139"],"gpt_icon":0},{"id":"2585650159","title":"GENFIT 9-Months 2025 Revenue €39.2 Million; Says As of September 30, 2025, The Company's Cash And Cash Equivalents Amounted To €119.0 Million Compared With €107.5 Million As Of June 30, 2025, And €81.8 Million As Of December 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2585650159","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585650159?lang=en_us&edition=fundamental","pubTime":"2025-11-21 01:13","pubTimestamp":1763658827,"startTime":"0","endTime":"0","summary":"Cash and cash equivalents totaled €119.0 million as of September 30, 2025€39.2 million in revenues for the nine months ended September 30, 2025, including the €26.5 million milestone payment following pricing and","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48982509/genfit-9-months-2025-revenue-39-2-million-says-as-of-september-30-2025-the-companys-cash-and-cash-e","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNFTF"],"gpt_icon":0},{"id":"2582587462","title":"GENFIT Unveils Promising Preclinical Data for ACLF Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2582587462","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582587462?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:28","pubTimestamp":1762781332,"startTime":"0","endTime":"0","summary":"Genfit SA ( ($GNFT) ) just unveiled an update. On November 10, 2025, GENFIT presented promising preclinical data for its investigational drug G1090...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfit-unveils-promising-preclinical-data-for-aclf-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfit-unveils-promising-preclinical-data-for-aclf-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF","BK4139"],"gpt_icon":0},{"id":"2582874545","title":"GENFIT Collaborates with EVerZom to Advance Exosome-Based Therapy for ACLF","url":"https://stock-news.laohu8.com/highlight/detail?id=2582874545","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582874545?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:28","pubTimestamp":1762781317,"startTime":"0","endTime":"0","summary":"Genfit SA ( ($GNFT) ) just unveiled an update. On November 10, 2025, GENFIT announced a research collaboration with EVerZom to advance exosome-base...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfit-collaborates-with-everzom-to-advance-exosome-based-therapy-for-aclf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfit-collaborates-with-everzom-to-advance-exosome-based-therapy-for-aclf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF","BK4139"],"gpt_icon":0},{"id":"2579031801","title":"Genfit announces intention to voluntarily delist ADSs from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2579031801","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579031801?lang=en_us&edition=fundamental","pubTime":"2025-10-31 05:10","pubTimestamp":1761858657,"startTime":"0","endTime":"0","summary":"Genfit (GNFT) announced it has given formal notice to the Nasdaq Stock Market of its intention to voluntarily delist its American Depositary Shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genfit-announces-intention-to-voluntarily-delist-adss-from-nasdaq-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genfit-announces-intention-to-voluntarily-delist-adss-from-nasdaq-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSQ","USAW.SI","QLD",".IXIC","NQmain","BK4139","GNFT","USJW.SI","NVIW.SI","QID","TQQQ","MNQmain","GNFTF","SQQQ","TSYW.SI"],"gpt_icon":0},{"id":"2579918974","title":"GENFIT Showcases ACLF Pipeline Advances at AASLD Liver Meeting 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2579918974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579918974?lang=en_us&edition=fundamental","pubTime":"2025-10-29 05:27","pubTimestamp":1761686857,"startTime":"0","endTime":"0","summary":"An update from Genfit SA ( ($GNFT) ) is now available. On October 28, 2025, GENFIT announced its participation in the upcoming AASLD The Liver Meet...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfit-showcases-aclf-pipeline-advances-at-aasld-liver-meeting-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfit-showcases-aclf-pipeline-advances-at-aasld-liver-meeting-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GNFTF"],"gpt_icon":0},{"id":"2569703265","title":"Genfit Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2569703265","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569703265?lang=en_us&edition=fundamental","pubTime":"2025-09-24 19:10","pubTimestamp":1758712200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GNFT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 24, 2025 07:10 ET (11:10 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNFTF"],"gpt_icon":0},{"id":"2569877043","title":"Genfit price target lowered to $7 from $9 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2569877043","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569877043?lang=en_us&edition=fundamental","pubTime":"2025-09-24 18:10","pubTimestamp":1758708612,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on Genfit (GNFT) to $7 from $9 and keeps a Buy rating on the shares. The company last week announce...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genfit-price-target-lowered-to-7-from-9-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genfit-price-target-lowered-to-7-from-9-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF"],"gpt_icon":0},{"id":"2569723127","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Genfit (OtherGNFTF), Sanofi (OtherSNYNF) and Roche Holding AG (OtherRHHVF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2569723127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569723127?lang=en_us&edition=fundamental","pubTime":"2025-09-24 09:40","pubTimestamp":1758678004,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Genfit (GNFTF – Research Report), Sanofi (SNYNF – ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-genfit-othergnftf-sanofi-othersnynf-and-roche-holding-ag-otherrhhvf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-genfit-othergnftf-sanofi-othersnynf-and-roche-holding-ag-otherrhhvf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4210","BK4588","GNFTF","SNYNF","XLV","BK4585","AG","LABU","BK4581","BK4007","HCSG","BK4139","BK4137","XBI"],"gpt_icon":0},{"id":"2569658757","title":"Genfit’s 2025 Mid-Year Financial and Strategic Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2569658757","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569658757?lang=en_us&edition=fundamental","pubTime":"2025-09-23 11:52","pubTimestamp":1758599576,"startTime":"0","endTime":"0","summary":"Genfit ( ($GNFT) ) has released its Q2 earnings. Here is a breakdown of the information Genfit presented to its investors. Genfit is a French bioph...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfits-2025-mid-year-financial-and-strategic-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfits-2025-mid-year-financial-and-strategic-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF","BK4139"],"gpt_icon":0},{"id":"2569821765","title":"Genfit SA Reports Revenue Decline and Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2569821765","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569821765?lang=en_us&edition=fundamental","pubTime":"2025-09-23 11:52","pubTimestamp":1758599559,"startTime":"0","endTime":"0","summary":"Genfit SA ( ($GNFTF) ) has released its Q2 earnings. Here is a breakdown of the information Genfit SA presented to its investors. Genfit SA is a Fr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfit-sa-reports-revenue-decline-and-net-loss?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfit-sa-reports-revenue-decline-and-net-loss?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNFTF"],"gpt_icon":0},{"id":"2569730551","title":"Genfit H1 EPS $(0.23) Down From $0.57 YoY, Sales $40.443M Down From $65.887M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2569730551","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569730551?lang=en_us&edition=fundamental","pubTime":"2025-09-23 04:11","pubTimestamp":1758571917,"startTime":"0","endTime":"0","summary":"Genfit (NASDAQ:GNFT) reported quarterly losses of $(0.23) per share. This is a 140.35 percent decrease over earnings of $0.57 per share from the same period last year.  The company reported $40.443 million in sales this","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/09/47806266/genfit-h1-eps-0-23-down-from-0-57-yoy-sales-40-443m-down-from-65-887m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Genfit H1 EPS $(0.23) Down From $0.57 YoY, Sales $40.443M Down From $65.887M YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNFTF"],"gpt_icon":0},{"id":"2568299026","title":"Genfit Discontinues VS-01 in ACLF After Safety Signal","url":"https://stock-news.laohu8.com/highlight/detail?id=2568299026","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568299026?lang=en_us&edition=fundamental","pubTime":"2025-09-20 04:39","pubTimestamp":1758314356,"startTime":"0","endTime":"0","summary":"Genfit  said late Friday that it will discontinue its VS-01 program in Acute-on-Chronic Liver Failure after a serious adverse event in a trial and feedback from its data monitoring committee.The company plans to shift VS-01 development to Urea Cycle Disorder, highlighting its promise in treating acute hyperammonemic crises in pediatric patients, according to the report.The decision will cut costs, extend its cash runway beyond 2028, and provide flexibility to advance ACLF programs and pursue new opportunities, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VS","BK4139","BK4085","GNFT","GNFTF"],"gpt_icon":0},{"id":"2568129181","title":"GENFIT Discontinues VS-01 Program in ACLF to Focus on UCD","url":"https://stock-news.laohu8.com/highlight/detail?id=2568129181","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568129181?lang=en_us&edition=fundamental","pubTime":"2025-09-20 04:27","pubTimestamp":1758313661,"startTime":"0","endTime":"0","summary":"An announcement from Genfit SA ( ($GNFT) ) is now available. On September 19, 2025, GENFIT announced the discontinuation of its VS-01 program for A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genfit-discontinues-vs-01-program-in-aclf-to-focus-on-ucd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genfit-discontinues-vs-01-program-in-aclf-to-focus-on-ucd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4085","VS","BK4139","GNFTF"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}